We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.8%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.4B
AUM Growth
+$1.11B
(+5.8%)
Cap. Flow
+$100M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
18.19%
Holding
3,316
New
217
Increased
1,367
Reduced
1,468
Closed
167
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$43.9M |
| 2 |
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
|
+$31.7M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$27.7M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$26.5M |
| 5 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$44.6M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$30.3M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$30.3M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$30.2M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$28.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.45% |
| 2 | Financials | 4.68% |
| 3 | Healthcare | 4.07% |
| 4 | Consumer Discretionary | 3.92% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Aclaris Therapeutics
ACRS
$860M
| $124K | ﹤0.01% |
15,338
| – | – |
|
2927
SelectQuote
SLQT
$124M
| $124K | ﹤0.01% |
57,292
+20,500
| +56% | +$33.1K |
|
|
SVC
2928
Service Properties Trust
SVC
$1.1B
| $123K | ﹤0.01% |
2,463
-214
| -8% | -$9.9K |
|
|
EMX
2929
DELISTED
EMX Royalty
EMX
| $122K | ﹤0.01% |
+61,547
| New | +$122K |
|
2930
Equinox Gold
EQX
$13.5B
| $122K | ﹤0.01% |
23,761
+10,954
| +86% | +$45.6K |
|
|
CLDT
2931
Chatham Lodging
CLDT
$590M
| $121K | ﹤0.01% |
11,534
| – | – |
|
|
FTCH
2932
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $121K | ﹤0.01% |
24,657
+5,107
| +26% | +$27.7K |
|
2933
Bausch Health
BHC
$2.32B
| $120K | ﹤0.01% |
14,782
+365
| +3% | +$2.93K |
|
2934
OFS Capital
OFS
$48.6M
| $120K | ﹤0.01% |
11,700
| – | – |
|
2935
BGC Group
BGC
$5.12B
| $119K | ﹤0.01% |
22,672
+3,607
| +19% | +$16.5K |
|
2936
AdvisorShares Pure Cannabis ETF
YOLO
$33.2M
| $119K | ﹤0.01% |
41,012
-1,396
| -3% | -$4.83K |
|
2937
Amplify Seymour Cannabis ETF
CNBS
$76.3M
| $118K | ﹤0.01% |
2,336
+695
| +42% | +$41.1K |
|
2938
Dole
DOLE
$1.23B
| $118K | ﹤0.01% |
10,070
| – | – |
|
2939
FuelCell Energy
FCEL
$1.73B
| $118K | ﹤0.01% |
1,376
+33
| +2% | +$3.25K |
|
2940
VanEck Mortgage REIT Income ETF
MORT
$373M
| $118K | ﹤0.01% |
+10,408
| New | +$128K |
|
2941
ASE Group
ASX
$102B
| $117K | ﹤0.01% |
14,697
-671
| -4% | -$4.9K |
|
|
ZTR
2942
Virtus Total Return Fund
ZTR
$341M
| $117K | ﹤0.01% |
18,002
-4,905
| -21% | -$32.3K |
|
|
NNDM
2943
Nano Dimension
NNDM
$344M
| $115K | ﹤0.01% |
39,840
+444
| +1% | +$1.19K |
|
|
ADAM
2944
Adamas Trust
ADAM
$913M
| $115K | ﹤0.01% |
11,542
-744
| -6% | -$8.06K |
|
|
LPTV
2945
DELISTED
Loop Media, Inc.
LPTV
| $115K | ﹤0.01% |
+20,000
| New | +$116K |
|
2946
BRC Inc
BRCC
$215M
| $114K | ﹤0.01% |
22,107
+3,765
| +21% | +$23.6K |
|
|
FT
2947
Franklin Universal Trust
FT
$198M
| $114K | ﹤0.01% |
15,972
-1,165
| -7% | -$8.2K |
|
|
LEO
2948
BNY Mellon Strategic Municipals
LEO
$387M
| $114K | ﹤0.01% |
18,328
-1,680
| -8% | -$10.6K |
|
2949
MasterBrand
MBC
$1.87B
| $114K | ﹤0.01% |
14,168
-27,948
| -66% | -$246K |
|
|
MQT
2950
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $113K | ﹤0.01% |
10,907
-98
| -0.9% | -$1.02K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Cambridge Investment Research Advisors held 3,316 positions worth $20.4B, up 5.8% from $19.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q1 2023 filing shows 217 new, 1,367 increased, 1,468 reduced and 167 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $44.6M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.
- Cambridge Investment Research Advisors's largest Q1 2023 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M.
- Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $43.9M increase.
- Cambridge Investment Research Advisors's biggest Q1 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $44.6M.
- Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q1 2023, selling an estimated $4.61M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $20.4B portfolio in Q1 2023.
- Cambridge Investment Research Advisors opened 217 new positions and closed 167 in Q1 2023.
- Cambridge Investment Research Advisors's portfolio value rose 5.8% quarter-over-quarter to $20.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.